Noninvasive point-of-care 13C-Methacetin Breath Test (MBT) predicts risk of clinical deterioration independently of currently used prognostic indicators in patients with decompensated NASH cirrhosis

Autor:	John Vierling, Arun Sanyal, Scott Friedman, Mitchell Shiffman, Jean Chan, Raphael Werner, Jaime Bosch
Rok vydání:	2020
Předmět:	Hepatology
Zdroj:	Journal of Hepatology. 73:S139-S140
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(20)30789-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2c33b26ce2286f26c4bc32cc3a3b2006 https://doi.org/10.1016/s0168-8278(20)30789-3 Zobrazit plný text záznamu Full Text from ScienceDirect